Ebola Virus–Specific Neutralizing Antibody Persists at High Levels in Survivors 2 Years After Resolution of Disease in a Sierra Leonean Cohort is a research paper published in The Journal of Infectious Diseases (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01 AI123535
National Institutes of Health
Grant: U01 5U01AI151812
NHLBI NIH HHS
Grant: R38 HL155774
NIAID NIH HHS
Grant: U01 AI151812
NIAID NIH HHS
Grant: U19 AI135995
National Institutes of Health
Grant: 5R01AI123535-03
Clinical Sequelae and Urogenital Viral Dynamics in Survivors of Ebola Virus Disease
National Institutes of Health
Grant: 1U01AI151812-01
West African Emerging Infectious Disease Research Center (WA-EIDRC)
Infectious Diseases
West African Research Network
Infectious Diseases
West African Research Network
FWCI
0.60
Citation Percentile
0.6%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals